Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Bexxar

Antibodies Avastin, Bexxar, Erbitux, Herceptin, Humaspect, Humira, Mabcampath/Campath-Hl, Mabthera/ Rituxan, Mylotarg, Neutrospec, Oncoscint, Orthoclone OKT-3, Prostascint, Raptiva, Remicade, Simulect, Synagis, Xolair, Zenapax, Zevalin... [Pg.32]

Bexxar (tositumomab murine monoclonal raised against CD 20 surface antigen, found on the surface of B-lymphocytes) Corixa and GlaxoSmithKline Non-Hodgkin s lymphoma... [Pg.381]

Tositumomab (Bexxar) Radiolabeled MoAb to CD20 Refractory low-grade lymphoma Phase II... [Pg.447]

Bexxar Tositumomab Corixa, Seattle, WA (originally Coulter Pharmaceuticals) and GlaxoSmithKline, Middlesex, England Radiolabeled anti-CD20 Non-Hodgkin s lymphoma 2003... [Pg.580]

Tositumomab Bexxar CD20-positive, follicular, non-Hodgkin s lymphoma 2003 (not by EMEA)d ... [Pg.88]

Bexxar Tositumomab Murine igCU CD20 B-cell NHL IV 450 mg tositumomab and 131I-tositumomab by dosimetry 1 Dose (65-75 cGy)... [Pg.313]

Tositumomab Bexxar Chimeric (hu/mu) anti-CD20 + 1-131 Immunoconjugate 6/27/2003... [Pg.577]

Tositumomab-I131 Bexxar Corixa Anti-CD20 Iodine 131 IgG2a Lambda Oncology 2003... [Pg.591]

Monoclonal antibody-based product Bexxar Corixa/Glaxo Smith Kline CD20 cells 2003... [Pg.53]

Tositumomab 1-131 Bexxar (Corixa/GSK) CD20 + follicular non-Hodgkins lymphoma... [Pg.273]

Although no radioimmunoconjugates have progressed to the market, a number have been examined in clinical trials. Bexxar ( I-tositumomab) is an anti-CD20 MoAb examined in Phase III trials for... [Pg.1138]

Bexxar- tositumomab Idamycin - idarubicin Rubex - doxorubicin... [Pg.395]

Trade names Bexxar (Corixa) (GSK) Iodine131 l-Tositumomab (MDS Nordion) Tositumomab Indications Non-Hodgkin lymphoma Category Antineoplastic Monoclonal antibody Half-life 8.04 days... [Pg.583]

Bexxar, 131I-anti-CD20 Non-Hodgkin s Corixa Corp, and FDA approved 15... [Pg.368]

GREGORY, S.A., et al., Bexxar (tositumomab, iodine-131 tositumomab) can be safely administered in relapsed low-grade non-Hodgkin s lymphoma patients after prior treatment with rituximab Initial experience from the expanded access study. Oncology 14 (2000). [Pg.179]

Tositumomab and Iodine 1 131 Tositumomab Bexxar Corixa Corp. [Pg.332]

Plosker GL, Figgitt DP. Rituximab a review of its use in non-Hodgkin s lymphoma and chronic lymphocytic leukemia. Drugs 2004 63 803-843. Anonymous. Iodine-131 tositumomab [Bexxar] for treatment of lymphoma. Med Lett 2003 45 86-87. [Pg.2327]

Radioimmunotherapy. The recent approval of the anti-CD20 radioimmunoconjugates I-tositumomab (Bexxar) and °Y-ibritumomab tiuxetan (Zevalin) has provided clinicians with a novel treatment option for patients with indolent NHLs. Both I-tositumomab and °Y-ibritumomab tiuxetan are mouse antibodies linked to a radioisotope, either iodine 131 I) or yttrium 90 Y). [Pg.2457]

See other pages where Bexxar is mentioned: [Pg.1380]    [Pg.452]    [Pg.112]    [Pg.114]    [Pg.723]    [Pg.204]    [Pg.211]    [Pg.136]    [Pg.310]    [Pg.119]    [Pg.385]    [Pg.393]    [Pg.396]    [Pg.419]    [Pg.194]    [Pg.114]    [Pg.634]    [Pg.936]    [Pg.1422]    [Pg.400]    [Pg.639]    [Pg.682]    [Pg.364]    [Pg.367]    [Pg.2317]    [Pg.310]    [Pg.91]   
See also in sourсe #XX -- [ Pg.419 ]

See also in sourсe #XX -- [ Pg.368 ]

See also in sourсe #XX -- [ Pg.91 ]

See also in sourсe #XX -- [ Pg.905 ]

See also in sourсe #XX -- [ Pg.574 ]



SEARCH



Murine antibody Bexxar

© 2024 chempedia.info